ZNF384 and cervical cancer: The results unequivocally demonstrated a substantially increased binding affinity of ZNF384 to the predicted INTS13 promoter region in primary cervical cancer cells (pCCa-1, pCCa-2, pCCa-3) when compared to human cervical epithelial cells (priCEpi-1) (Fig. 9G).